Literature DB >> 24696449

A maternal gluten-free diet reduces inflammation and diabetes incidence in the offspring of NOD mice.

Camilla Hartmann Friis Hansen1, Lukasz Krych2, Karsten Buschard3, Stine B Metzdorff4, Christine Nellemann5, Lars H Hansen6, Dennis S Nielsen2, Hanne Frøkiær4, Søren Skov4, Axel K Hansen4.   

Abstract

Early-life interventions in the intestinal environment have previously been shown to influence diabetes incidence. We therefore hypothesized that a gluten-free (GF) diet, known to decrease the incidence of type 1 diabetes, would protect against the development of diabetes when fed only during the pregnancy and lactation period. Pregnant nonobese diabetic (NOD) mice were fed a GF or standard diet until all pups were weaned to a standard diet. The early-life GF environment dramatically decreased the incidence of diabetes and insulitis. Gut microbiota analysis by 16S rRNA gene sequencing revealed a pronounced difference between both mothers and their offspring on different diets, characterized by increased numbers of Akkermansia, Proteobacteria, and TM7 in the GF diet group. In addition, pancreatic forkhead box P3 regulatory T cells were increased in GF-fed offspring, as were M2 macrophage gene markers and tight junction-related genes in the gut, while intestinal gene expression of proinflammatory cytokines was reduced. An increased proportion of T cells in the pancreas expressing the mucosal integrin α4β7 suggests that the mechanism involves increased trafficking of gut-primed immune cells to the pancreas. In conclusion, a GF diet during fetal and early postnatal life reduces the incidence of diabetes. The mechanism may involve changes in gut microbiota and shifts to a less proinflammatory immunological milieu in the gut and pancreas.
© 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24696449     DOI: 10.2337/db13-1612

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  45 in total

1.  Targeting gut microbiota and barrier function with prebiotics to alleviate autoimmune manifestations in NOD mice.

Authors:  Camilla H F Hansen; Christian S Larsen; Henriette O Petersson; Line F Zachariassen; Andreas Vegge; Charlotte Lauridsen; Witold Kot; Łukasz Krych; Dennis S Nielsen; Axel K Hansen
Journal:  Diabetologia       Date:  2019-05-28       Impact factor: 10.122

Review 2.  The crucial role of early-life gut microbiota in the development of type 1 diabetes.

Authors:  He Zhou; Lin Sun; Siwen Zhang; Xue Zhao; Xiaokun Gang; Guixia Wang
Journal:  Acta Diabetol       Date:  2020-07-25       Impact factor: 4.280

Review 3.  Antibiotics, gut microbiota, environment in early life and type 1 diabetes.

Authors:  Youjia Hu; F Susan Wong; Li Wen
Journal:  Pharmacol Res       Date:  2017-02-07       Impact factor: 7.658

Review 4.  Microbiota and autoimmunity: exploring new avenues.

Authors:  Leonid A Yurkovetskiy; Joseph M Pickard; Alexander V Chervonsky
Journal:  Cell Host Microbe       Date:  2015-05-13       Impact factor: 21.023

5.  Colonic Lesions, Cytokine Profiles, and Gut Microbiota in Plasminogen-Deficient Mice.

Authors:  Bill Vestergaard; Łukasz Krych; Leif R Lund; Bettina P Jørgensen; Lars Hansen; Henrik E Jensen; Dennis S Nielsen; Axel K Hansen
Journal:  Comp Med       Date:  2015-10       Impact factor: 0.982

Review 6.  Maternal influences on fetal microbial colonization and immune development.

Authors:  Joann Romano-Keeler; Jörn-Hendrik Weitkamp
Journal:  Pediatr Res       Date:  2014-10-13       Impact factor: 3.756

7.  Cutting Edge: Commensal Microbiota Has Disparate Effects on Manifestations of Polyglandular Autoimmune Inflammation.

Authors:  Camilla H F Hansen; Leonid A Yurkovetskiy; Alexander V Chervonsky
Journal:  J Immunol       Date:  2016-06-20       Impact factor: 5.422

Review 8.  Type 1 diabetes and gut microbiota: Friend or foe?

Authors:  Changyun Hu; F Susan Wong; Li Wen
Journal:  Pharmacol Res       Date:  2015-03-05       Impact factor: 7.658

9.  Strategies to promote abundance of Akkermansia muciniphila, an emerging probiotics in the gut, evidence from dietary intervention studies.

Authors:  Kequan Zhou
Journal:  J Funct Foods       Date:  2017-03-29       Impact factor: 4.451

10.  Sex-dependent effects of bisphenol A on type 1 diabetes development in non-obese diabetic (NOD) mice.

Authors:  Joella Xu; Guannan Huang; Tamas Nagy; Quincy Teng; Tai L Guo
Journal:  Arch Toxicol       Date:  2019-01-02       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.